Cargando…

Long-Term Effectiveness of Cilostazol in Patients with Hemodialysis with Peripheral Artery Disease

Aim: The aim of this study was to investigate the effects of continuous cilostazol use on emergency department (ED) visits, hospitalizations, and vascular outcomes in patients with hemodialysis (HD) with peripheral artery disease (PAD). Methods: This retrospective cohort study recruited 558 adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chung-Kuan, Lin, Chia-Hsun, Yar, Noi, Kao, Zih-Kai, Yang, Ya-Bei, Chen, Yun-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406651/ https://www.ncbi.nlm.nih.gov/pubmed/36216573 http://dx.doi.org/10.5551/jat.63404

Ejemplares similares

High Inferior Vena Cava Diameter with High Left Ventricular End Systolic Diameter as a Risk Factor for Major Adverse Cardiovascular Events, Cardiovascular and Overall Mortality among Chronic Hemodialysis Patients
por: Wu, Chung-Kuan, et al.
Publicado: (2022)

Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study
por: Lim, Paik Seong, et al.
Publicado: (2016)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

Peripheral Nerve Denervation in Streptozotocin-Induced Diabetic Rats Is Reduced by Cilostazol
por: Tseng, Kuang-Yi, et al.
Publicado: (2023)

Effect of Cilostazol on Patients With Diabetes Who Underwent Endovascular Treatment for Peripheral Artery Disease
por: Cha, Jung‐Joon, et al.
Publicado: (2023)

Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats
por: Cheng, Kuang-I., et al.
Publicado: (2022)

Long term effects of cilostazol in a dog with sick sinus syndrome
por: KANNO, Nobuyuki, et al.
Publicado: (2017)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database
por: Real, Jordi, et al.
Publicado: (2018)

Cilostazol ameliorates atrial ionic remodeling in long-term rapid atrial pacing dogs
por: Zhao, Zhiqiang, et al.
Publicado: (2016)

Long-term management of high-grade atrioventricular block using cilostazol in a cat
por: Iwasa, Naoki, et al.
Publicado: (2019)

Abdominal Obesity is Associated with Peripheral Artery Disease in Hemodialysis Patients
por: Hung, Peir-Haur, et al.
Publicado: (2013)

Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study
por: Lee, Tsong-Hai, et al.
Publicado: (2020)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Statins Improve Long Term Patency of Arteriovenous Fistula for Hemodialysis
por: Chang, Hao-Hsiang, et al.
Publicado: (2016)

Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation
por: Sun, Fei, et al.
Publicado: (2015)

Indoxyl Sulfate and Incident Peripheral Artery Disease in Hemodialysis Patients
por: Lin, Ting-Yun, et al.
Publicado: (2020)

Dual Antiplatelet Therapy Using Cilostazol in Patients With Stroke and Intracranial Arterial Stenosis
por: Uchiyama, Shinichiro, et al.
Publicado: (2021)

Association of adiponectin with peripheral arterial disease and mortality in nondiabetic hemodialysis patients: Long-term follow-up data of 7 years
por: Zhou, Yijun, et al.
Publicado: (2016)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Cilostazol ameliorates diabetic nephropathy by inhibiting high-glucose-induced apoptosis
por: Chian, Chien-Wen, et al.
Publicado: (2020)

Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion
por: Kitamura, Akihiro, et al.
Publicado: (2017)

Long-Term Cilostazol Treatment and Predictive Factors on Outcomes of Endovascular Intervention in Patients with Diabetes Mellitus and Critical Limb Ischemia
por: Lee, Chiu-Yang, et al.
Publicado: (2020)

Real world data from a multi-centre study on the effects of cilostazol on pain symptoms and walking distance in patients with peripheral arterial disease
por: Katsiki, Niki, et al.
Publicado: (2022)

Risk of Heart Failure Hospitalization Associated With Cilostazol in Diabetes: A Nationwide Case–Crossover Study
por: Wu, Cho-Kai, et al.
Publicado: (2019)

Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis
por: Chang, Chiz-Tzung, et al.
Publicado: (2017)

Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study
por: Lin, Chin-Sheng, et al.
Publicado: (2015)

Current Perspective on Hemodialysis Patients with Peripheral Artery Disease
por: Okamoto, Shin, et al.
Publicado: (2017)

Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis
por: Lu, Chien-Lin, et al.
Publicado: (2016)

Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9
por: Chen, I-Chih, et al.
Publicado: (2017)

Cilostazol Reduces PAC-1 Expression on Platelets in Ischemic Stroke
por: Lee, Su-Yun, et al.
Publicado: (2008)

Lingual amyloidosis in a long-term hemodialysis patient
por: Chen, Chien-Chin, et al.
Publicado: (2018)

Plasma Protein Characteristics of Long-Term Hemodialysis Survivors
por: Lin, Yao-Ping, et al.
Publicado: (2012)

Link between Peripheral Artery Disease and Heart Rate Variability in Hemodialysis Patients
por: Chen, Szu-Chia, et al.
Publicado: (2015)

Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
por: Ke, Ke, et al.
Publicado: (2015)

Cilostazol plus clopidogrel in the prevention of in-stent stenosis after vertebral artery origin stenting in gout patients: three case reports
por: Yuan, Huai-Wu, et al.
Publicado: (2020)

Combination of cilostazol and clopidogrel attenuates Rat critical limb ischemia
por: Sheu, Jiunn-Jye, et al.
Publicado: (2012)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_12ussbhcokmlr5nd84o4ms5clc